Phase I pharmacokinetic studies estimate parent-molecule oral bioavailability in the range of 4-16%
The Clinical Bottom Line on BPC-157 in Miami BPC-157 is a legitimately interesting recovery peptide, but it is not a product you should be buying off a website and guessing your way through
What community members commonly report: Sustained or gradually improving energy levels Continued skin quality improvements Stable or improving bloodwork markers Some report a general sense of improved resilience and well-being A subset report minimal or no lasting changes Realistic expectation: The rest period between courses (typically 3-6 months) is part of the protocol, not downtime
GIP may reduce oxidative stress in endothelial cells and visceral adipose tissue and decrease the secretion of inflammatory cytokines [36]
[Updated 2023 Apr 26]
Topical GHK-Cu, Serums, Eye Creams, and Injectable GHK-Cu Topical GHK-Cu appears in published skin-care studies, wound-healing research, and clinical-trial protocols, while injectable GHK-Cu is treated differently by FDA compounding-risk materials [2], [7], [8]